33% of Type 1 Diabetes Patients Insulin-Free With Stem Cells at AshTip Solution.

AshTip NewsLetter |SAN DIEGO — An investigational allogeneic stem cell–derived pancreatic islet cell replacement therapy (VX-880, Vertex Pharmaceuticals) continues to show promise as a treatment for type 1 diabetes, according to the latest data, from six patients thus far.

Medscape

33% of Type 1 Diabetes Patients Insulin-Free With Stem Cells

33% of Type 1 Diabetes Patients Insulin-Free With Stem Cells

SAN DIEGO — An investigational allogeneic stem cell–derived pancreatic islet cell replacement therapy (VX-880, Vertex Pharmaceuticals) continues to show promise as a treatment for type 1 diabetes, according to the latest data, from six patients thus far.